Aurora Cannabis Inc. ACB ACB and MedReleaf Australia launched CraftPlant, a new medical cannabis brand for patients in the Australian market.
The CraftPlant brand includes three new products available for doctors to prescribe – Greendae, Navana and HiVolt. All three are THC-dominant with high percentages of terpenes. The cultivars were developed by Occo, Aurora's science and genetics business. The new range is produced under EU-GMP certified conditions and will be available in 10g containers.
"Through our partnership with MedReleaf Australia, we are proud to continue to lead the way in the Australian market with the addition of new and innovative products for patients," stated Miguel Martin, CEO of Aurora Cannabis. "As we build on our strategic international growth plans, Australia has proven to be a very promising and sustainable cannabis market that we are committed to."
Aurora currently holds a 10% ownership stake in MedReleaf Australia, a fully licensed, private company. Together, they provide Australian patients with several Aurora-branded products, including dried flower, oils and soft gels.
Russell Harding, CEO of MedReleaf Australia stated, "These new products are the result of dedicated hard work by the teams in both Canada and Australia, providing the most unique cannabis cultivars available in the Australian medical market. With CraftPlant, doctors now have 27 MedReleaf products available for their patients, providing a wide range of possible solutions for patients unable to obtain relief from their prior medications or treatment, and produced under the strictest guidelines."
Benzinga's Cannabis Capital Conference Is Back
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.
Photo: Courtesy of CNW Group/Aurora Cannabis Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!